Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.60    0.00 (0.00%)
Bid:
10.20
Ask:
11.00
Spread: 0.80 (7.843%)
Market Cap: £14.73m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Total Voting Rights

20 Mar 2026 16:17

RNS Number : 5452X
Ebiquity PLC
20 March 2026
 

20 March 2026

 

Ebiquity Plc

("the Company" or "Ebiquity")

 

Total Voting Rights

 

The Company notifies that, following the proposed cancellation of 40,749 ordinary shares of 25p ("Ordinary Shares"), its ordinary share capital will consist of 141,215,531 Ordinary Shares. 

 

The proposed cancellation of 40,749 Ordinary Shares follows an amendment ("Amendment") to the terms of the sale and purchase agreement dated 29 March 2022 ("SPA") for the acquisition of the entire issued share capital of Media Management, LLC ("MML"), pursuant to which 679,158 Ordinary Shares (the "Consideration Shares") were issued to the MML Vendors in part payment of the deferred consideration, as announced on 29 July 2025. The Amendment sets a minimum price, being the nominal value of the Company's Ordinary Shares, at which the Consideration Shares may be issued.

 

Pursuant to the Amendment, the number of Consideration Shares to satisfy that portion of the deferred consideration has been re-calculated to be 638,409 Ordinary Shares. As a result, the MML Vendors will transfer back 40,749 Ordinary Shares to the Company for nil consideration and the Ordinary Shares so transferred will be cancelled.

 

The Ebiquity plc Employee Benefit Trust ("EBT") holds 2,262,845 Ordinary Shares to satisfy awards under the Company's share options plans. The trustee of the EBT has agreed not to vote the Ordinary Shares held by it such that these Ordinary Shares are treated as not carrying voting rights.

 

Therefore, following the cancellation of 40,749 Ordinary Shares, the total voting rights in the Company will be 141,215,531. This figure may be used by shareholders as the denominator for calculations to determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Capitalised terms in this announcement shall have the same meaning as in the acquisition announcement on 30 March 2022.

 

Enquiries:

 

Ebiquity plc

Dorcas Murray, Company Secretary

 +44 (0) 20 7650 9600

 

Camarco

Geoffrey Pelham-Lane/ Ben Woodford

ebiquity@camarco.co.uk

Cavendish Capital Markets

Nominated Advisor and Sole Broker

Ben Jeynes/ George Lawson - Corporate Finance

 +44 (0) 20 7220 0500

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

 

 

 

 

About Ebiquity plc

 

Ebiquity is the independent authority in Marketing Effectiveness. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

 

Our work is driven by over 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

For further information, please visit: www.ebiquity.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRURANRNNUOUAR
Date   Source Headline
11th Mar 20152:16 pmRNSExercise of Share Options
26th Feb 20152:14 pmRNSAcquisition of Media Value
16th Feb 201512:45 pmRNSExercise of Share Options
13th Feb 20153:50 pmRNSAcquisition and issue of shares
6th Feb 201510:34 amRNSDirector/PDMR Shareholding
4th Feb 20155:00 pmRNSHolding(s) in Company
2nd Feb 20152:55 pmRNSHolding(s) in Company
28th Jan 20157:00 amRNSInterim Results
19th Jan 20158:45 amRNSExercise of Share Options
8th Jan 20154:28 pmRNSHolding(s) in Company
27th Nov 20147:00 amRNSExercise of Share Options
24th Nov 20143:00 pmRNSDirector Dealing
24th Nov 20142:59 pmRNSHolding(s) in Company
24th Nov 20142:55 pmRNSDirector Dealing and Exercise of Share Options
21st Nov 20147:00 amRNSAppointment of Non-Executive Directors
21st Nov 20147:00 amRNSTrading update
14th Nov 20143:22 pmRNSDirector Dealing
11th Nov 20149:10 amRNSDirector Dealing
10th Sep 201411:57 amRNSResult of AGM
6th Aug 20147:00 amRNSAnnual Report
31st Jul 20143:49 pmRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
3rd Jul 20147:00 amRNSNew Debt Facility
13th Jun 20148:30 amRNSAppointment of MD, South East Asia
16th May 201411:33 amRNSAward of share options
8th May 20147:00 amRNSAcquisition
14th Apr 20147:00 amRNSAppointment of CEO, Americas
7th Apr 20147:00 amRNSPayment of deferred consideration
19th Mar 20147:00 amRNSChange of Registered Office
13th Mar 20143:05 pmRNSHolding(s) in Company
11th Mar 20145:32 pmRNSExercise of Share Options
7th Mar 20141:04 pmRNSExercise of Share Options
7th Mar 20147:00 amRNSDirectors' dealings and directorate changes
6th Mar 20147:00 amRNSDirectorate
3rd Mar 201412:02 pmRNSHolding(s) in Company
21st Feb 20149:32 amRNSHolding(s) in Company
20th Feb 20145:45 pmRNSHolding in Company / Issue of Equity
13th Feb 201411:00 amRNSHolding in Company / Issue of Equity
13th Feb 201410:24 amRNSHolding(s) in Company
12th Feb 201410:34 amRNSHolding(s) in Company
7th Feb 201412:50 pmRNSHolding(s) in Company
7th Feb 201412:10 pmRNSHolding(s) in Company
6th Feb 201412:02 pmRNSHolding(s) in Company
5th Feb 20144:49 pmRNSHolding(s) in Company
22nd Jan 20145:34 pmRNSExercise of Share Options
21st Jan 20144:06 pmRNSExercise of Share Options
17th Jan 20144:24 pmRNSDirector/PDMR Shareholding
15th Jan 20147:00 amRNSInterim Results
15th Jan 20147:00 amRNSAcquisition
15th Jan 20147:00 amRNSConclusion of Review of Strategic Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.